1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow End-Stage Renal Disease: new trials by email Literature Review of End-Stage Renal Disease trials Research Report on End-Stage Renal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroid Withdrawal in Pediatric Kidney Transplant Recipients Basiliximab, Cyclosporine, Tacrolimus - End-Stage Renal Disease | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 274 | 2001-01-01 | 2016-10-21 |
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Basiliximab (1) · Cyclosporine (1) · Methylprednisolone (1) · Prednisone (1) · Sirolimus (1) · Tacrolimus (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
Mexico (1) · United States (1)